FDA 510(k)
FDA class 2
Substantially Equivalent
🇺🇸 United States
VITEK 2 AST-Yeast Voriconazole (<= 0.03125 - >= 4 µg/mL)
K Number: K232967
·
Decision Jun 12, 2024
Classifications
1
FEI Numbers
7
Registration Numbers
7
Same Product Code
20
Applicant Total
29
Review Days
265
Basic Information
- Device Name
- VITEK 2 AST-Yeast Voriconazole (<= 0.03125 - >= 4 µg/mL)
- K Number
- K232967
- Device Class
- FDA class 2
- Clearance Type
- Traditional
- Regulation Number
- 866.1640
- Medical Specialty
- Microbiology
- Decision
- Substantially Equivalent
- Statement or Summary
- Summary
- Applicant
- bioMerieux, Inc.
- Date Received
- September 21, 2023
- Decision Date
- June 12, 2024
- Product Code
- NGZ
- Advisory Committee
- Microbiology
- Review Advisory Committee
- MI
- Third Party
- N
Classifications
This FDA 510(k) entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| NGZ | Susceptibility Test Plate, Antifungal | FDA class 2 | Microbiology |
Similar 510(k) Clearances
Other 510(k) clearances with the same product code (NGZ), ordered by most recent decision date.
The Sensititre YeastOne Susceptibility System with Micafungin in the dilution range of 0.008-16 µg/mL
FDA 510(k)
FDA Class 2
·Microbiology
VITEK 2 AST-Yeast Anidulafungin (<= 0.015 - >= 8 µg/mL)
FDA 510(k)
FDA Class 2
·Microbiology
The Sensititre YeastOne Susceptibility System with Rezafungin in the dilution range of 0.008-8ug/mL
FDA 510(k)
FDA Class 2
·Microbiology
Sensititre YeastOne Susceptibility System with Fluconazole in the dilution range of 0.12-128ug/mL
FDA 510(k)
FDA Class 2
·Microbiology
The Sensititre YeastOne Susceptibility System with Caspofungin in the dilution range of 0.015-16ug/ml
FDA 510(k)
FDA Class 2
·Microbiology
Sensititre YeastOne Susceptibility System with Voriconazole in the dilution range of 0.008 - 8 ug/mL
FDA 510(k)
FDA Class 2
·Microbiology
Other Clearances by bioMerieux, Inc.
| K Number | Device Name | ||
|---|---|---|---|
| K232963 | VITEK 2 AST-Yeast Anidulafungin (<= 0.015 - >= 8 µg/mL) | Jun 7, 2024 | Substantially Equivalent |
| K234000 | VITEK 2 AST-Gram Positive Lefamulin (<=0.03 - >=4 µg/mL) | Mar 11, 2024 | Substantially Equivalent |
| K222378 | VITEK 2 AST-Gram Negative Levofloxacin (</=0.125 ->/=8 ug/mL) | Jun 26, 2023 | Substantially Equivalent |
| K213899 | VITEK 2 AST-Yeast Caspofungin (<=0.125 - >=8 µg/mL), VITEK 2 AST-YS Caspofungin (<=0.125 - >=8 µg/mL), VITEK 2 AST-YS Caspofungin | Jul 12, 2022 | Substantially Equivalent |
| K213931 | VITEK 2 AST-Gram Negative Omadacycline (<=0.25 - >=16 µg/mL) | Jun 3, 2022 | Substantially Equivalent |
| K212461 | VITEK MS PRIME | Mar 15, 2022 | Substantially Equivalent |
| K202396 | VITEK 2 AST-Gram Positive Fosfomycin (<=8 - >=256 ug/mL) | Sep 14, 2021 | Substantially Equivalent |
| K201675 | VITEK 2 AST-Gram Negative Meropenem (<= 0.25 - >=16 µg/mL) | Jul 9, 2021 | Substantially Equivalent |
| K191766 | VITEK 2 AST-Gram Negative Eravacycline (<=0.12 - >=4µg/mL) | Aug 5, 2019 | Substantially Equivalent |
| K190616 | VITEK 2 AST-Gram Positive Dalbavancin (<= 0.015 - >= 1 µg/mL) | Jun 6, 2019 | Substantially Equivalent |